Medicare would pay pharmacists directly for testing common illnesses

What does this do?

This bill would let Medicare Part B pay pharmacists directly for testing and treating patients for COVID-19, flu, RSV, and strep throat, plus services during declared public health emergencies. Pharmacists would still need to follow state rules, which may require physician supervision or collaboration. Payment would be 80% of actual charge or 85% of the standard Medicare physician rate (100% during emergencies), with no balance billing allowed, starting January 1, 2026.

Who does it affect?

Medicare patients, typically those 65 and older or with certain disabilities, who could seek testing and treatment at pharmacies. Pharmacists and physicians who may work under new payment and collaboration arrangements are also affected.

Why does it matter?

The change would shift where and how certain Medicare patients access testing and treatment for common illnesses, moving some care from doctor's offices to pharmacies. It would also formalize payment arrangements between pharmacists and Medicare that don't currently exist.

Where does it stand?